PRESTIGE-AF is the first of the larger trials in this scenario to report results. More data are needed to help guide ...
The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: ...
Ischemic stroke is a fatal condition caused by an arterial embolism that blocks the blood flow through the cerebral artery, frequently being a cause of mortality and disability. Fibroblast growth ...
Penumbra's thrombectomy growth and new products show promise, but high valuation at 7x 2025 revenue tempers appeal for GARP ...
With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...
Pulmonary embolism is the third leading cause of cardiovascular death behind heart attack and stroke. The signs of this ...
Phase III PRESTIGE-AF trial shows that direct oral anticoagulants significantly lower the risk of ischemic stroke in ...
12don MSN
A 35-year-old man suffered an almost fatal stroke when an artery ruptured in his neck—caused by a sneeze. According to his ...
The global Thrombectomy Devices Market, valued at US$ 1.7 billion in 2022, is projected to advance at a compound annual ...
The Wonder Woman star has opened up about the terrifying ordeal she went through when she was eight months pregnant ...
Opens in a new tab or window Direct oral anticoagulants were associated with lower risks of ischemic stroke or systemic embolism and bleeding compared with warfarin. The study included patients ...
Under the terms of the agreement, Kyorin will receive $55m upfront and will be eligible for milestone payments of up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback